MedTrace Logo

A Prospective Research Investigation of Ischemia Using MCG

NCT06481943 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-10-21

No results posted yet for this study

Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

Sponsor MCG device (CardiAQ)

Unshielded magnetocardiography device for measuring cardiac magnetic fields

Sponsors & Collaborators

Principal Investigators

  • Kit Yee Au-Yeung, PhD · SB Technology, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-11
Primary Completion
2026-03-31
Completion
2026-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06481943 on ClinicalTrials.gov